TMRW Job Title: Lead Frontend Software Developer


The Lead Frontend Software Developer will be responsible for architecting / development / deployment of our healthcare applications / products and managing off-shore team. 

The Lead Frontend Software Developer should have extensive experience in Vue.js and other frontend development tools  


  • Manage and coach a team of talented off-shore front-end software engineers

  • Own and refine architecture of systems that span multiple teams and/or products

  • Maintain a culture that focuses on quality, continuous improvement and learning opportunities

  • Build UI front-end with vanilla Javascript and Vue.js for healthcare data products

  • Define/design features for the product in an agile environment

  • Hands on development

  • Deliver user-facing visualizations

  • Coordinate with DevOps and Data Architecture teams to define data schematics and workflow

  • Translate user requirements into interactively designed interfaces for applications/products

  • Support UX Design


  • Bachelor's in Computer Science or related with 5+ years of experience

  • Proven initiative and ability to champion a project from conception through to implementation

  • Strong desire to grow developers and improve existing practices to produce high-quality software

  • Experience working in a test-driven development, or strong desire to implement and improve testing practices

  • JavaScript expertise 

  • Extensive experience in Vue.js

  • Experience with one or more of the following: Angular, React, Backbone, Ember

  • Knowledge of other tools you might need (git, Java, SQL, etc.)

  • Mobile UX familiarity

To apply, send an email with the job description to



Manhattan-based TMRW is a mission-driven company on track to become the first mover in automating the IVF lab by creating the first fertility cryostorage center of excellence in the world. TMRW features fully robotic freezers, 100 percent physical and digital chain of custody, continuous monitoring of egg and embryo samples and electronically integrated processes—all overseen at the TMRW control center. The firm is structured in anticipation of an IPO with leading assisted reproductive technology (ART) physicians as customers, clinical partners and significant equity holders.